Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn’s Disease Patients

[1]  R. Chou,et al.  American Gastroenterological Association Institute Technical Review on the Management of Crohn's Disease After Surgical Resection. , 2017, Gastroenterology.

[2]  Siddharth Singh,et al.  American Gastroenterological Association Institute Guideline on the Management of Crohn's Disease After Surgical Resection. , 2017, Gastroenterology.

[3]  M. Regueiro,et al.  Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. , 2016, Gastroenterology.

[4]  O. Faiz,et al.  Concomitant colonic disease (Montreal L3) and re‐resectional surgery are predictors of clinical recurrence following ileocolonic resection for Crohn's disease , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[5]  M. Kamm,et al.  Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis , 2015, Alimentary pharmacology & therapeutics.

[6]  D. Sorrentino.  State-of-the-art medical prevention of postoperative recurrence of Crohn's disease , 2013, Nature Reviews Gastroenterology &Hepatology.

[7]  C. Sánchez-Montes,et al.  Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. , 2012, World journal of gastroenterology.

[8]  M. Geraci,et al.  Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn’s Disease: Partial Benefit by Infliximab—A Pilot Study , 2012, Digestive Diseases and Sciences.

[9]  Takayuki Yamamoto,et al.  Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: A prospective pilot study , 2009, Inflammatory bowel diseases.

[10]  S. Hanauer,et al.  Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis , 2009, The American Journal of Gastroenterology.

[11]  M. Regueiro,et al.  Infliximab prevents Crohn's disease recurrence after ileal resection. , 2009, Gastroenterology.

[12]  J. Terdiman.  Prevention of postoperative recurrence in Crohn's disease. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  C. Avellini,et al.  Prevention of postoperative recurrence of Crohn's disease by infliximab. , 2006, European journal of gastroenterology & hepatology.

[14]  D. Sachar.  Recurrence rates in Crohn’s disease: predicting the future and predicting the past , 2005, Gut.

[15]  A. Taschieri,et al.  Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. , 2004, Gastroenterology.

[16]  R. Thisted,et al.  Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. , 2004, Gastroenterology.

[17]  G. Hellers,et al.  Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease , 2000, The British journal of surgery.

[18]  H. Buhr,et al.  Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. , 1999, European journal of gastroenterology & hepatology.

[19]  M. Cottone,et al.  Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. , 1997, Gastroenterology.